Blood tests to assess electrolyte levels and renal function may be appropriate, particularly for those at higher risk (older adults, those with kidney disease, or taking medications that affect electrolytes)
Their capsules give you a steady 300mg dose each time
Their reasoning includes the potentially significant systemic side effects of stopping semaglutide and the lack of evidence for a causative link between GLP-1 RAs and NAION
Pilot clinical studies and case reports describe nausea in 65% of subjects at doses above 0,5 mg (resolution 2-4 h post-injection), flushing in 55%, transient increases in blood pressure and tachycardia in 40-60% of subjects, with peak acute effects occurring 90-120 minutes post-dose
That's the whole honest pitch
10.1111/j.1528-1167.2008.01491.x Epilepsia 63 SharmaH